Avalo Therapeutics (AVTX) Total Debt (2014 - 2023)
Avalo Therapeutics (AVTX) reported Total Debt of $14.12 million for Q2 2023, down 24.6% from $18.71 million a year earlier and down 28.6% from the prior quarter.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Total Debt (2014 - 2023) Analysis & Trends
At the end of FY2022, Avalo Therapeutics posted Total Debt of $19.42 million, down 40.9% from FY2021.
- Total Debt has a four-year compound annual growth rate of 6.0% (FY2018 to FY2022).
- By year, Total Debt came in at $32.83 million in FY2021 and $15.38 million in FY2018.
- The Q2 2023 figure ranks as the lowest quarterly Total Debt since Q2 2017.
- Per Business Quant data, the three quarters before Q2 2023 came in at $19.77 million (Q1 2023), $19.42 million (Q4 2022) and $19.07 million (Q3 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Avalo Therapeutics | 304.12 Mn | -388.10 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 14.12 Mn |
| Mar 31, 2023 | 19.77 Mn |
| Dec 31, 2022 | 19.42 Mn |
| Sep 30, 2022 | 19.07 Mn |
| Jun 30, 2022 | 18.71 Mn |
| Mar 31, 2022 | 33.18 Mn |
| Dec 31, 2021 | 32.83 Mn |
| Sep 30, 2021 | 32.48 Mn |
| Jun 30, 2021 | 17.14 Mn |
| Sep 30, 2019 | 15.30 Mn |
| Jun 30, 2019 | 15.33 Mn |
| Mar 31, 2019 | 15.35 Mn |
| Dec 31, 2018 | 15.38 Mn |
| Sep 30, 2018 | 15.40 Mn |
| Jun 30, 2018 | 15.43 Mn |
| Mar 31, 2018 | 15.38 Mn |
| Jun 30, 2017 | 607,598.00 |
| Mar 31, 2017 | 1.49 Mn |
| Dec 31, 2016 | 2.35 Mn |
| Sep 30, 2016 | 3.19 Mn |
API Access
Avalo Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();